BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23975633)

  • 1. Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors.
    Li SH; Wei W; Guo RP; Shi M; Guo ZX; Chen ZY; Xiao CZ; Cai MY; Zheng L
    Med Oncol; 2013 Dec; 30(4):696. PubMed ID: 23975633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
    Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
    HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    J Gastrointest Surg; 2015 Jul; 19(7):1281-90. PubMed ID: 25956724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
    Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
    Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.
    Du M; Chen L; Zhao J; Tian F; Zeng H; Tan Y; Sun H; Zhou J; Ji Y
    BMC Cancer; 2014 Jan; 14():38. PubMed ID: 24460749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.
    Zhang H; Yuan SX; Dai SY; Zhang JM; Huang X; Lu CD; Lu JH; Wu FQ; Lau WY; Wu MC; Yang T; Shen F
    World J Surg; 2014 Apr; 38(4):947-57. PubMed ID: 24258262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.
    Sumie S; Nakashima O; Okuda K; Kuromatsu R; Kawaguchi A; Nakano M; Satani M; Yamada S; Okamura S; Hori M; Kakuma T; Torimura T; Sata M
    Ann Surg Oncol; 2014 Mar; 21(3):1002-9. PubMed ID: 24254204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma.
    Nitta H; Allard MA; Sebagh M; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Lewin M; Samuel D; Baba H; Adam R
    Ann Surg Oncol; 2019 Aug; 26(8):2568-2576. PubMed ID: 31054040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.
    Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y
    Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
    Schlichtemeier SM; Pang TC; Williams NE; Gill AJ; Smith RC; Samra JS; Lam VW; Hollands M; Richardson AJ; Pleass HC; Nozawa S; Albania M; Hugh TJ
    Eur J Surg Oncol; 2016 Oct; 42(10):1576-83. PubMed ID: 27378158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
    Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
    BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.
    Chen JL; Lao XM; Lin XJ; Xu L; Cui BK; Wang J; Lin GH; Shuang ZY; Mao YZ; Huang X; Yun JP; Jin JT; Li SP
    Medicine (Baltimore); 2016 Feb; 95(5):e2665. PubMed ID: 26844496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.